PET/CT scan to see if a new drug is working in advanced lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial tests whether a special PET/CT scan can show how well a Trop2-targeting drug is working in people with advanced lung cancer that has already been treated. It aims to improve how we monitor treatment response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older)
- You have advanced NSCLC that has spread and has been treated before
- You have at least one tumor that can be measured on scans
- You are willing to have two extra PET/CT scans using a radioactive tracer called 68Ga-MY6349
- Your overall health is good (ECOG score 0 or 1)
- You can give your informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET scan to see if a type of drug called Trop2-ADC is working in people with advanced breast cancer. The scan may help doctors decide if the treatment is right for you.
This study tests whether a new imaging agent called 68Ga-MY6349 can help detect tumors during a PET/CT scan. If you are an adult with a solid tumor (newly diagnosed or already treated), you may be able to take part in this research to see if the new tracer works better than standard imaging.
This trial tests a new imaging scan (two types of PET/CT) to see how well it tracks tumor response to a TROP2-targeted drug in people with EGFR-mutant lung cancer that stopped responding to standard pills. It aims to improve how doctors measure treatment success.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
This study uses a special PET/CT scan that targets a protein called c-Met to help diagnose and stage non-small cell lung cancer. It aims to see if this imaging method can better identify tumor locations and characteristics.
This trial uses a special PET scan to find a protein called Trop-2 on your cancer cells. It helps doctors decide if a targeted treatment (Trop-2 ADC) might work for you.
Hear when a new Trop2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.